In the U.S. where adoption is highest, fewer than 1 in 10 adults are on a GLP-1 drug, despite nearly three-quarters being overweight or obese. Globally access is even more limited, held back by high ...

An experimental daily weight loss pill has helped some people shed 12.4 per cent of their body weight in a milestone trial. Development of weight loss drugs has become something of an arms race in ...